Skip to main content
Tech.euFundingExplorerBeta

Healthtech funding in February 2023

European Healthtech startup funding raised during February 2023.

In February 2023, 54 European Healthtech companies closed 54 funding rounds and raised €412M in equity funding (excluding debt and grants), down 47.5% versus February 2022. Debt rounds added €168M. Germany led by capital raised, and European Innovation Council (EIC) was the most active investor. Data as of 20 Nov 2026.

Equity funding
€412M
-47.5% vs February 2022 · excl. debt & grants · +€168M debt
Funding rounds
54
-10.0% vs February 2022
Companies
54
Top country
Germany
Rank among sectors
#3
12.5% of sector funding
Debt financing
€168M
29.0% of total
Top-10 round share
76.7%
of disclosed capital
Rounds ≥ €100M
2

Top countries

by € raised
Healthtech — top countries by capital, February 2023 — interactive chart.
Data table
Healthtech — top countries by capital, February 2023
Germany€163M
Denmark€127M
UK€114M
Switzerland€53M
Finland€24M
France€23M
Estonia€18M
Sweden€18M

Stage mix

by € raised
Healthtech — stage mix, February 2023 — interactive chart.
Data table
Healthtech — stage mix, February 2023
Debt€168M
Series B€157M
Other€154M
Series A€47M
Series D+€32M
Seed€20M
Pre-Seed€1.8M
Growth/Late€1.0M

Exits & M&A

3 Acquisition

3 exits · €30M disclosed.

Diamond WhitesAcquisitionFeb 2023€30M

Top deals

largest disclosed rounds in February 2023
CompanyStageDateAmount
EvotecDebtFeb 2023€150M
Hemab TherapeuticsSeries BFeb 2023€127M
XeltisSeries D+Feb 2023€32M
ProkariumOtherFeb 2023€28M
EvonetixSeries BFeb 2023€22M
Tilt BiotherapeuticsOtherFeb 2023€22M
IcosagenDebtFeb 2023€18M
SyntachOtherFeb 2023€18M
Maxion TherapeuticsSeries AFeb 2023€15M
OculisOtherFeb 2023€14M
DrDoctorOtherFeb 2023€11M
PhloSeries AFeb 2023€11M
DxcoverSeries AFeb 2023€11M
Resalis TherapeuticsSeedFeb 2023€10M
Avicenna.aiSeries AFeb 2023€10M

Top investors

most active in February 2023, by deal count